ClinConnect ClinConnect Logo
Search / Trial NCT06730724

Thenar Muscle Ultrasound in CTS Evaluation

Launched by BEYLIKDUZU STATE HOSPITAL · Dec 9, 2024

Trial Information

Current as of August 21, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a new way to evaluate carpal tunnel syndrome (CTS) using ultrasound technology. CTS is a condition that affects the wrist and can cause pain, numbness, and weakness in the hand. The study will involve 20 patients aged 18-75 who have been diagnosed with CTS within the last three months, alongside 20 healthy volunteers who do not have CTS. Researchers will gather information about participants' age, gender, and other health details, and assess hand strength using special tools. They will also use ultrasound to look at certain muscles in the hand and the median nerve, which is often affected in CTS.

To be eligible for the study, participants must be between 18 and 75 years old and have a recent diagnosis of CTS. Healthy volunteers are welcome too. However, people who have had surgery for CTS, have certain nerve or muscle diseases, or have other specific health issues will not be able to participate. The study is not yet recruiting participants, but if you join, you can expect a thorough evaluation of your hand strength and an ultrasound examination. This research aims to improve understanding and treatment of CTS, which could help many people in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients aged 18-75 years.
  • Diagnosed with carpal tunnel syndrome based on electrophysiological examination within the last 3 months.
  • Healthy volunteers without a diagnosis of carpal tunnel syndrome.
  • Volunteered to participate in the study.
  • Exclusion Criteria:
  • Refusal to participate in the study.
  • History of surgery due to carpal tunnel syndrome.
  • Presence of neuromuscular diseases.
  • Presence of advanced osteoarthritis.
  • Presence of psychiatric disorders.
  • Presence of cognitive impairments that may hinder study participation.

About Beylikduzu State Hospital

Beylikduzu State Hospital is a leading healthcare institution located in Istanbul, Turkey, dedicated to advancing medical research and improving patient care through innovative clinical trials. As a government-funded facility, it prioritizes patient safety and ethical standards while fostering collaboration among healthcare professionals, researchers, and regulatory bodies. With a commitment to utilizing cutting-edge technology and evidence-based practices, Beylikduzu State Hospital aims to contribute significantly to the development of new therapies and treatment protocols that enhance health outcomes for diverse populations.

Locations

Istanbul, Beylikdüzü, Turkey

Istanbul, , Turkey

Patients applied

0 patients applied

Trial Officials

Büşra Şirin Ahısha

Principal Investigator

Beylikdüzü State Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported